Skip to main content
VCbacked
Log inGet Started

Aisthesis Medical

London, United Kingdom

Aisthesis Medical specializes in providing AI-driven decision support for acute care to prevent complications and enhance patient outcomes.

$1.2M raised
Oct 2025
Pre-Seed
Health CareMedical

Top Investors

Twin Path VenturesCentre for Process InnovationEureka NetworkReady2ScaleTECS Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aisthesis Medical

How much funding has Aisthesis Medical raised?
Aisthesis Medical has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2025.
Who are Aisthesis Medical's investors?
Aisthesis Medical's investors include Twin Path Ventures, Centre for Process Innovation, Eureka Network, Ready2Scale, TECS Capital.
Where is Aisthesis Medical headquartered?
Aisthesis Medical is headquartered in London, United Kingdom.
What does Aisthesis Medical do?
Aisthesis Medical specializes in providing AI-driven decision support for acute care to prevent complications and enhance patient outcomes.
What stage is Aisthesis Medical at?
Aisthesis Medical is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aisthesis Medical — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/aisthesis-medical. Accessed June 17, 2026.
APA
VCBacked. (2025). Aisthesis Medical — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/aisthesis-medical
Wikipedia (cite web)
{{cite web |title=Aisthesis Medical — Funding & Investors |url=https://www.vcbacked.co/company/aisthesis-medical |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K